Franklin Street Properties (FSP) lags fourth-quarter FFO and revenue estimates
FRanklin Street Properties (FSP) exited with quarterly funds from operations (FFO) of $0.10 per share, missing Zacks consensus estimate of $0.12 per share. That compares to an FFO of $0.16 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents a surprise FFO of -16.67%. A quarter ago, this hybrid real estate investment trust was expected to post an FFO of $0.13 per share when it actually produced an FFO of $0.14, delivering a surprise 7, 69%.
In the past four quarters, the company has only exceeded FFO’s consensus estimate once.
The sustainability of the immediate stock price movement based on recently released numbers and future FFO expectations will primarily depend on management’s comments on the earnings call.
Franklin Street shares have lost about 7.1% year-to-date versus a -7.7% decline for the S&P 500.
What’s next for Franklin Street?
As Franklin Street has outperformed the market so far this year, the question on investors’ minds is: what’s next for the stock?
There is no easy answer to this key question, but a reliable metric that can help investors solve this problem is the company’s FFO outlook. This includes not only current FFO consensus expectations for the upcoming quarter(s), but also how those expectations have changed recently.
Empirical research shows a strong correlation between short-term stock movements and trends in estimate revisions. Investors can track these revisions on their own or rely on a proven rating tool like Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.
Prior to this earnings release, the trend in Franklin Street estimate revisions is mixed. While the magnitude and direction of estimate revisions may change following the release of the company’s earnings report, the current situation translates into a No. 3 (hold) Zacks ranking for the stock. Thus, the shares should move in line with the market in the near future. You can see the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how the estimates for the next few quarters and the current fiscal year change in the days ahead. The current FFO consensus estimate is $0.12 on $42.55 million in revenue for the upcoming quarter and $0.49 on $171.87 million in revenue for the current fiscal year.
Investors should be aware that the outlook for the sector can also have a significant impact on stock performance. In terms of Zacks industry rankings, REITs and Equity Trust – Other are currently in the bottom 30% of Zacks more than 250 industries. Our research shows that the top 50% of industries ranked by Zacks outperform the bottom 50% by a factor of more than 2 to 1.
Another stock in the same sector, Sabra Healthcare (SBRA), has not yet released its results for the quarter ended December 2021. The results are expected to be released on February 22.
This healthcare real estate investment trust is expected to post quarterly earnings of $0.36 per share in its next report, representing a year-over-year change of -14.3%. The consensus EPS estimate for the quarter has been revised upwards by 0.5% in the past 30 days from the current level.
Sabra Healthcare revenue is expected to be $153.94 million, up 1.2% from the prior year quarter.
Zacks names ‘only one best choice for doubling up’
From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.
It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could step in at any time.
This company could rival or surpass other recent Zacks stocks that are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.
Free: See our best stock and our 4 finalists >>
Click to get this free report
Franklin Street Properties Corp. (FSP): free stock analysis report
Sabra Healthcare REIT, Inc. (SBRA): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.